India's No.1 Weekly For The Pharmaceutical Industry
About us || Feedback|| Advertising || Subscribe || Archives / Search 

Issue dated - 03rd October 2002

Home > Edit

Editorial
Tests of Intentions
Asking India to incorporate Data Exclusivity provisions in its patent Act at this point of time signals the pressure tactics that are being employed to test the intentions of the Government of India on its WTO commitments, especially concerning the TRIPS.

Edit Article
Ups and downs in drug development
Among the responses received to my earlier articles, one of the key points made was that all ragaglitazar related events were part of a normal drug development process.

INSIDE PHARMA

HAPPENNINGS

CORPORATE

EDITORIAL

POLICIES & AMEND.

SCRIPS

BULK DRUG TRENDS

TECHNOLOGY TRENDZ

MARKETPLACE
CONVERSATION
RESEARCH
BIOTECH
 PRODUCTS
APIs
BACK PAGE


Advanced Search
ARCHIVES
SUBSCRIBE
CUSTOMER SERVICE
CONTACT US
ADVERTISE
ABOUT US

 Network Sites

  Express Computer

  IT People
  Network Magazine
  Business Traveller
  Hotelier & Caterer
  Travel & Tourism
  Exp. Backwaters
  Healthcare Mgmt.
  Express Textile
 Group Sites
  ExpressIndia
  Indian Express
  Financial Express
<Top of page>
ABOUT US FEEDBACK ADVERTISE SUBSCRIBE ARCHIVES
 


© Copyright 2000: Indian Express Group (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by
The Business Publications Division of the Indian Express Group of Newspapers. Please contact our Webmaster for any queries on this site.